Ftse Mib
39.224,71
1,32%
DAX
22.794,11
1,78%
S&P 500
5.956,06
0,01%
NASDAQ
19.075,26
0,26%
Bitcoin
84.928,63
1,04%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Stoke Therapeutics Inc (STOK) Stoke Therapeutics Inc (STOK) Notizie

Stoke Therapeutics Inc

STOK
8,27
0,02 (0,24%)
27 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/2/202522:30BWStoke Therapeutics to Present at Upcoming Investor..
18/2/202522:31EDGAR2Form 8-K - Current report
18/2/202514:00BWBiogen and Stoke Therapeutics Enter into Collaboration to..
08/1/202522:30BWStoke Therapeutics to Present at the 43rd Annual J.P. Morgan..
07/1/202513:06EDGAR2Form 8-K - Current report
07/1/202513:00BWStoke Therapeutics Announces Alignment with Global..
06/1/202522:30BWStoke Therapeutics to Host Webcast to Discuss Successful..
27/12/202423:23EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
27/12/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/12/202400:15EDGAR2Form 144 - Report of proposed sale of securities
11/12/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202422:48EDGAR2Form 144 - Report of proposed sale of securities
06/12/202423:19EDGAR2Form 8-K - Current report
06/12/202418:00BWStoke Therapeutics Presents New Open-Label Extension (OLE)..
05/12/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202413:00BWStoke Therapeutics Receives FDA Breakthrough Therapy..
03/12/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202414:00BWStoke Therapeutics Announces Plans to Present New Data that..
14/11/202415:00EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
05/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202413:05EDGAR2Form 8-K - Current report
05/11/202413:00BWStoke Therapeutics Reports Third Quarter Financial Results..
01/11/202421:50EDGAR2Form 144 - Report of proposed sale of securities
09/10/202422:16EDGAR2Form S-3ASR - Automatic shelf registration statement of..
02/10/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202422:22EDGAR2Form SC 13D/A - General Statement of Acquisition of..
19/9/202423:23EDGAR2Form 144 - Report of proposed sale of securities
10/9/202422:17EDGAR2Form 8-K - Current report
10/9/202413:00BWStoke Therapeutics Presents Zorevunersen Data Showing..
05/9/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202414:00BWStoke Therapeutics Appoints Eric Olson, MS, MBA as Chief..
03/9/202414:00BWStoke Therapeutics to Present at Upcoming Investor..
16/8/202422:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
07/8/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202413:05EDGAR2Form 8-K - Current report
07/8/202413:00BWStoke Therapeutics Reports Second Quarter Financial Results..
05/8/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202422:25EDGAR2Form 144 - Report of proposed sale of securities
16/7/202422:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
18/6/202422:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
13/6/202422:06EDGAR2Form S-3 - Registration statement under Securities Act of..
07/6/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 8,25 Min: 8,13 Max: 8,368
Chiusura: 8,25

La tua Cronologia

NASDAQ
STOK
Stoke Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci